Econazole
Econazole, Ecoza (econazole) is a small molecule pharmaceutical. Econazole was first approved as Spectazole on 1982-12-23. It is used to treat cutaneous candidiasis, mycoses, tinea pedis, and tinea versicolor in the USA. It is known to target transient receptor potential cation channel subfamily V member 5 and transient receptor potential cation channel subfamily M member 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Econazole, Ecoza (discontinued: Econazole, Spectazole)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Econazole nitrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ECOZA | Resilia Pharmaceuticals | N-205175 RX | 2013-10-24 | 1 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| 071023 econazole nitrate 1% / niacinamide 4% | unapproved drug other | 2020-07-02 |
| econavix | ANDA | 2020-12-23 |
| econazole nitrate | ANDA | 2024-07-15 |
| econazole nitrate 1% / niacinamide 4% | unapproved drug other | 2019-05-20 |
| ecoza | New Drug Application | 2023-12-04 |
| pm external | unapproved drug other | 2019-03-19 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| mycoses | — | D009181 | B35-B49 |
| tinea pedis | EFO_0007512 | D014008 | B35.3 |
| tinea versicolor | EFO_0007439 | D014010 | B36.0 |
| cutaneous candidiasis | — | D002179 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Econazole Nitrate, Ecoza, Resilia Pharms | |||
| 10071054 | 2031-08-08 | DP | |
ATC Codes
D: Dermatologicals
— D01: Antifungals for dermatological use
— D01A: Antifungals for topical use
— D01AC: Imidazole and triazole derivatives, topical antifungals
— D01AC03: Econazole
G: Genito urinary system and sex hormones
— G01: Gynecological antiinfectives and antiseptics
— G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
— G01AF: Imidazole derivatives, gyncological antiinfectives
— G01AF05: Econazole
— G01AF55: Econazole, combinations
HCPCS
No data
Clinical
Clinical Trials
9 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Otomycosis | D059249 | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Tinea | D014005 | EFO_0007510 | B35.9 | — | 2 | 3 | — | — | 5 |
| Tinea pedis | D014008 | EFO_0007512 | B35.3 | — | 2 | 3 | — | — | 5 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Onychomycosis | D014009 | — | B35.1 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Econazole |
| INN | econazole |
| Description | 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole is a member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 4-chlorobenzyl group. It is an ether, a member of imidazoles, a dichlorobenzene and a member of monochlorobenzenes. |
| Classification | Small molecule |
| Drug class | systemic antifungals (miconazole type) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 1069-66-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL808 |
| ChEBI ID | 82873 |
| PubChem CID | 3198 |
| DrugBank | DB01127 |
| UNII ID | 6Z1Y2V4A7M (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
TRPV5
TRPV5
TRPM2
TRPM2
Organism
Homo sapiens
Gene name
TRPV5
Gene synonyms
ECAC1
NCBI Gene ID
Protein name
transient receptor potential cation channel subfamily V member 5
Protein synonyms
Calcium transport protein 2, calcium transporter 2, CaT2, ECaC, ECaC1, Epithelial calcium channel 1, Osm-9-like TRP channel 3, OTRPC3
Uniprot ID
Mouse ortholog
Trpv5 (194352)
transient receptor potential cation channel subfamily V member 5 (Q2TB50)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Econazole
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,998 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
574 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use